{
  "docId": "019de070-fa64-77bc-8caf-8d60d9bebc40",
  "docSlug": "35e598705f15db6c29b5dc7bc3a9d06d",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 79 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 55,
  "pageCount": 79,
  "prevPage": 54,
  "nextPage": 56,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 112,
  "notes": "The slide includes two distinct tables: one for Revenue and one for Adj. Segment Profit/EBITA. It also includes a disclaimer about G&A and R&D allocation.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-fa64-77bc-8caf-8d60d9bebc40/55",
  "deckHref": "/decks/019de070-fa64-77bc-8caf-8d60d9bebc40",
  "deckJsonHref": "/decks/019de070-fa64-77bc-8caf-8d60d9bebc40.json",
  "deckAnchorHref": "/decks/019de070-fa64-77bc-8caf-8d60d9bebc40#slide-55",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.2,
        "x": 0.78,
        "y": 0.02
      },
      "kind": "callout",
      "text": "New Segment Structure",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2598e1c5-48ea-40ce-8f73-6529066a13eb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.2,
        "x": 0.77,
        "y": 0.87
      },
      "kind": "disclaimer",
      "text": "Does not reflect corporate G&A and R&D allocation",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49bf9922-6b7c-4ce2-b679-f547074fdae2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.04,
        "y": 0.87
      },
      "kind": "source-note",
      "text": "Footnotes 1-7 detailing financial reporting adjustments and segment definitions.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7973b37c-b142-490f-aafe-9aab072fd179",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.33,
        "w": 0.92,
        "x": 0.04,
        "y": 0.46
      },
      "kind": "table",
      "text": "Adj. Segment Profit/EBITA table showing Salix, International Rx, Ortho Dermatologics, and Diversified Products across 1Q21-FY18",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "62b2b8c3-71b0-4e9b-a99e-a71a9ef0c4d5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.33,
        "w": 0.92,
        "x": 0.04,
        "y": 0.11
      },
      "kind": "table",
      "text": "Revenue table showing Salix, International Rx, Ortho Dermatologics, and Diversified Products across 1Q21-FY18",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ffee7893-ce40-4c5b-a61e-319b36832c52",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.7,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Bausch Pharma Company Trailing Five Quarters",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d3e6d72-1130-4031-a498-c2a00fcdb003",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "1e8128a1-2827-4d3b-a985-a5ff54494903",
      "evidence": "table/data: Adj. Segment Profit/EBITA table showing Salix, International Rx, Ortho Dermatologics, and Diversified Products across 1Q21-FY18",
      "confidence": 0.9
    },
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "f6360640-0461-4aac-a7e5-843975790247",
      "evidence": "table/data: Revenue table showing Salix, International Rx, Ortho Dermatologics, and Diversified Products across 1Q21-FY18",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 79,
      "from": 21,
      "beatId": "4729803e-b632-425a-8f97-04c24718552b",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The company outlines its strategic plan and next steps",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}